UniFirst Announces Financial Results for the First Quarter of Fiscal 2017
Jan 04, 2017 13:03 pm UTC| Business
WILMINGTON, Mass., Jan. 04, 2017 -- UniFirst Corporation (NYSE:UNF) today announced results for its first quarter of fiscal 2017 which ended November 26, 2016. Revenues for the quarter were $386.1 million, up 3.4% from...
Atara Bio to Present at the 35th Annual J.P. Morgan Healthcare Conference
Jan 04, 2017 13:03 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Jan. 04, 2017 -- Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a biopharmaceutical company developing meaningful therapies for patients with severe and life-threatening diseases that have been...
Atara Bio to Present at the 35th Annual J.P. Morgan Healthcare Conference
Jan 04, 2017 13:03 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Jan. 04, 2017 -- Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a biopharmaceutical company developing meaningful therapies for patients with severe and life-threatening diseases that have been...
Atara Bio to Present at the 35th Annual J.P. Morgan Healthcare Conference
Jan 04, 2017 13:03 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Jan. 04, 2017 -- Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a biopharmaceutical company developing meaningful therapies for patients with severe and life-threatening diseases that have been...
Qorvo® and ubisys Team to Deliver First IoTivity Platform on a Multi-stack Chip
Jan 04, 2017 13:02 pm UTC| Business
GREENSBORO, N.C., Jan. 04, 2017 -- Qorvo® (Nasdaq:QRVO), a leading provider of innovative RF solutions that connect the world, and ubisys, a leading smart home and Internet of Things (IoT) company, have developed a new...
Qorvo® and ubisys Team to Deliver First IoTivity Platform on a Multi-stack Chip
Jan 04, 2017 13:02 pm UTC| Business
GREENSBORO, N.C., Jan. 04, 2017 -- Qorvo® (Nasdaq:QRVO), a leading provider of innovative RF solutions that connect the world, and ubisys, a leading smart home and Internet of Things (IoT) company, have developed a new...
Intra-Cellular Therapies to Present at the 35th Annual J.P. Morgan Healthcare Conference
Jan 04, 2017 13:02 pm UTC| Business
NEW YORK, Jan. 04, 2017 -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI) a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today announced that Sharon...